Enorama Pharma AB (publ) (STO:ERMA)
Sweden
· Delayed Price · Currency is SEK 0.280
0.00 (0.00%)
Apr 28, 2026, 5:09 PM CET
Enorama Pharma AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 3.04 | 2.09 | 6.15 | 4.14 | 12.2 | Upgrade
|
| Cash & Short-Term Investments | 3.04 | 2.09 | 6.15 | 4.14 | 12.2 | Upgrade
|
| Cash Growth | 45.66% | -66.11% | 48.66% | -66.07% | 157.71% | Upgrade
|
| Accounts Receivable | 1.72 | 0.21 | 0.02 | 1.95 | 7.06 | Upgrade
|
| Other Receivables | 0.58 | 1.2 | 2.03 | 2.37 | 1.45 | Upgrade
|
| Receivables | 2.3 | 1.41 | 2.05 | 4.32 | 8.5 | Upgrade
|
| Inventory | 1.75 | 11.28 | 4.29 | 2.84 | 1.24 | Upgrade
|
| Prepaid Expenses | 0.92 | 0.39 | 0.47 | 0.45 | 0.47 | Upgrade
|
| Other Current Assets | -0 | - | - | - | - | Upgrade
|
| Total Current Assets | 8 | 15.16 | 12.96 | 11.75 | 22.41 | Upgrade
|
| Property, Plant & Equipment | 0.01 | 0.14 | 0.86 | 1.54 | 2.22 | Upgrade
|
| Long-Term Deferred Charges | 0.25 | 0.59 | 20.56 | 23.43 | 26.3 | Upgrade
|
| Other Long-Term Assets | -0 | - | - | 12 | - | Upgrade
|
| Total Assets | 8.26 | 15.89 | 34.39 | 48.72 | 50.93 | Upgrade
|
| Accounts Payable | 6.5 | 1.17 | 3.72 | 5.35 | 2.18 | Upgrade
|
| Accrued Expenses | 3.37 | 1.5 | 4.02 | 2.04 | 2.24 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | 0.13 | 1.46 | 2.09 | Upgrade
|
| Current Income Taxes Payable | - | - | 0.29 | 0.43 | 0.39 | Upgrade
|
| Other Current Liabilities | 21.85 | 5.43 | 2.06 | 3.14 | 4.79 | Upgrade
|
| Total Current Liabilities | 31.71 | 8.09 | 10.22 | 12.43 | 11.68 | Upgrade
|
| Long-Term Debt | - | - | 0.3 | 0.45 | 1.7 | Upgrade
|
| Other Long-Term Liabilities | - | - | 4.33 | 4.33 | 16.2 | Upgrade
|
| Total Liabilities | 31.71 | 8.09 | 14.85 | 17.2 | 29.58 | Upgrade
|
| Common Stock | 11.66 | 9.45 | 6.39 | 1.46 | 1.2 | Upgrade
|
| Additional Paid-In Capital | 270.15 | 237.99 | 205.32 | 176.55 | 126.45 | Upgrade
|
| Retained Earnings | -305.25 | -239.64 | -192.18 | -149.07 | -106.29 | Upgrade
|
| Comprehensive Income & Other | - | - | - | 2.58 | - | Upgrade
|
| Shareholders' Equity | -23.45 | 7.8 | 19.54 | 31.52 | 21.35 | Upgrade
|
| Total Liabilities & Equity | 8.26 | 15.89 | 34.39 | 48.72 | 50.93 | Upgrade
|
| Total Debt | - | - | 0.44 | 1.91 | 3.79 | Upgrade
|
| Net Cash (Debt) | 3.04 | 2.09 | 5.72 | 2.23 | 8.41 | Upgrade
|
| Net Cash Growth | 45.66% | -63.53% | 156.37% | -73.49% | - | Upgrade
|
| Net Cash Per Share | 0.04 | 0.04 | 0.21 | 0.28 | 1.36 | Upgrade
|
| Filing Date Shares Outstanding | 74.59 | 60.47 | 40.93 | 25.86 | 7.69 | Upgrade
|
| Total Common Shares Outstanding | 74.59 | 60.47 | 40.93 | 9.35 | 7.69 | Upgrade
|
| Working Capital | -23.72 | 7.07 | 2.75 | -0.67 | 10.73 | Upgrade
|
| Book Value Per Share | -0.31 | 0.13 | 0.48 | 3.37 | 2.78 | Upgrade
|
| Tangible Book Value | -23.45 | 7.8 | 19.54 | 31.52 | 21.35 | Upgrade
|
| Tangible Book Value Per Share | -0.31 | 0.13 | 0.48 | 3.37 | 2.78 | Upgrade
|
| Machinery | - | 2.15 | 3.37 | 3.37 | 3.37 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.